|
|
|
|
|
DSS-IBD |
|
|
|
| Model: |
Dextran sulphate Sodium (DSS) induced colitis in mice |
|
| Animal: |
C57BL/6 mice |
|
| Inducer: |
DSS |
|
| Study duration: |
one week (in life) |
|
| Pathological features: |
- |
Colon inflammation |
|
- |
Crypt and epithelial cell damage with ulceration, tissue edema |
- |
Activation of the innate immune system |
|
| Suitability: |
- |
Study the innate immune system and epithelial barrier function |
|
| Parameter measures: |
- |
Body weight |
|
- |
Clinical score (stool consistence, occult bleeding) |
- |
Colon weight/colon length |
- |
Histo-pathology assessment |
- |
IHC |
- |
cytokine (ELISA or RT-qPCR, optional) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
The Latest Generation of Auto Patch Clamp Platform Launched at HDB  |
|
---------------------- |
WuXi Biology/HD Biosciences Presented at Webinar of "New Technologies for Target Discovery and Validation" |
|
---------------------- |
HD Biosciences Merges with WuXi AppTec |
|
|
|
|
|
|
|
|
|
|
沪公网安备 31011502003320号